Cardiovascular disease (CVD) is the leading cause of death worldwide. According to the World Health Organization (WHO), an estimated 17.9 million people die each year from CVD, and by 2030, this number is expected to reach 23.6 million.

The burden of CVD varies across countries and regions, and therefore, the strategies to prevent and manage CVD should be tailored to local conditions. To this end, Globocardio is a tool that helps estimate cardiovascular risk by country.

What is Globocardio?

Globocardio is a web-based tool that provides estimates of cardiovascular risk based on the WHO/International Society of Hypertension (ISH) risk prediction charts.

The charts were developed based on data from 17 studies that included over 700,000 adults from various regions of the world. The charts provide estimates of the 10-year risk of fatal or non-fatal CVD events (coronary heart disease, stroke, heart failure) based on age, sex, blood pressure, smoking status, and presence of diabetes or history of CVD.

How to use Globocardio?

Using Globocardio is easy – just follow these steps:.

Go to the Globocardio website (https://globocardio.org/)
Select your country
Enter your age, sex, blood pressure, smoking status, and diabetes status, if applicable
Click on “Calculate”

The tool will provide you with your estimated 10-year risk of CVD events, along with an indication of whether this risk is low, moderate, high, or very high, based on the WHO/ISH risk categories.

You can also print or download your results for later reference.

What are the benefits of using Globocardio?

Globocardio has several benefits:.

Provides personalized estimates of CVD risk based on individual characteristics and local conditions
Raises awareness about the importance of CVD prevention and management
Helps healthcare providers tailor interventions and treatment plans to individual patients
Allows policymakers to prioritize CVD prevention and control strategies based on local burden and risk factors

Limitations of Globocardio

Globocardio has some limitations that should be kept in mind when using it:.

The tool provides estimates of risk based on a set of assumptions and may not accurately reflect an individual’s actual risk.
The tool does not take into account other risk factors or comorbidities that may contribute to CVD risk, such as family history, cholesterol levels, and physical activity.
The tool requires accurate and up-to-date information on blood pressure and other risk factors, which may not always be available or accurate.

Conclusion

Globocardio is a valuable tool that helps estimate cardiovascular risk by country.

By providing personalized estimates of risk based on individual characteristics and local conditions, Globocardio can be used to raise awareness about the importance of CVD prevention and management, tailor interventions and treatment plans to individual patients, and prioritize CVD prevention and control strategies based on local burden and risk factors. However, the limitations of the tool should also be kept in mind when using it.